hotspot -WSS

hotspot

author：focus 2025-09-30 16:28:47 - browse：12524

An orange Flovent inhaler on a white background. -- health coverage from STAT — Adobe

As of Jan. 1, thousands of asthma patients in the U.S. will no longer be able to get refills for Flovent — one of the most popular inhalers in the U.S. for nearly 30 years.

Flovent’s manufacturer, GSK, has discontinued both versions of the product — Flovent HFA, an inhalation aerosol, and Flovent Diskus, an inhalation powder — and replaced each with what is known as an “authorized generic,” essentially the same product sold under a private label. Prasco, a U.S. drugmaker specializing in authorized generics, will distribute the new inhaler, sold as fluticasone.

The timing of the change is telling: Flovent’s price rose nearly 50% since 2014, according to GoodRx, leaving the drug vulnerable to the new Medicaid penalties going into effect as of this year for medications with price increases that outpace inflation. By discontinuing the brand-name inhaler but continuing to earn money from the authorized generic, GSK will be able to avoid paying a penalty.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Structure Therapeutics oral GLP

WSS

MultiPlan and major insurers sued for alleged medical price

Cancer researcher Catriona Jamieson is sending tumors into space

Stopping antidepressants leads to symptoms for 1 in 6 patients

Dogs on Prozac: What pet anti

Bird flu in milk supply is likely coming from asymptomatic cows

Data don't support strong claims for Covid

entertainment

hotspot

Wikipedia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Eli Lilly’s Zepbound improved liver scarring in mid

Medicare proposal to cover medical devices draws a mixed reaction

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Bright Health sells Medicare Advantage business to Molina

Medical bills so high, Medicare adding extra digits to claim forms

What does generative AI mean for health care? We asked experts

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

United colonoscopy coverage change 'may cost lives,' doctors say

Illumina board agrees to spin off Grail, as divestment plans proceed

knowledge

Why rehabilitation engineers need to center patients in their research

Dogs on Prozac: What pet anti

Exact Sciences stock tumbles despite strong cancer detection sales

Finland to offer bird flu vaccine to select groups of people, a possible global first

Element Biosciences CEO lays out genome sequencing strategy

BD to buy Edwards patient monitoring unit for $4.2 billion

knowledge

entertainment

knowledge

hotspot